1. Bayer's Blind Spot on Monsanto's Roundup May Cost Billions

    Bayer's Blind Spot on Monsanto's Roundup May Cost Billions

    (Bloomberg) -- There’s one more tribunal in which Bayer AG’s efforts to defend its Roundup weedkiller are floundering: the court of public opinion. Bayer says science shows that the herbicide, which the German company gained in its $63 billion acquisition of Monsanto Co., is safe. Now that a second U.S. jury has linked the product to cancer, the uphill battle Chief Executive Officer Werner Baumann is fighting just got steeper...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content

    1. It seemed like this trial would go a little bit differently, it would be a little bit more fact-based, little bit more science-based.
    2. We are disappointed with the jury's initial decision, but we continue to believe firmly that the science confirms that glyphosate-based herbicides do not cause cancer.
  3. Topics Mentioned